SF-MSC

N/A

Report date: 2023/01/12 15:46:22

Base Information

Drug NameSF-MSC

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Synovial fluid-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyBiologics > Exosomes > Stem cell-derived exosomes

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMeniscus InjuriesKnee InjuriesLeg Injuries +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTurkey

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Scientific And Technological Research Council Of Turkey

China Registration ClassN/A

Develop Information

Active CompaniesThe Scientific And Technological Research Council Of Turkey

Inactive CompaniesN/A

Active IndicationsMeniscus InjuriesKnee InjuriesLeg Injuries +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A